Tactile Systems Technology, Inc.

NasdaqGM:TCMD

Sector

🏥 Health Care

Industries

💻 Telehealth

🧬 Biotechnology

🔬 Clinical Trials

🏥 Hospitals & Clinics

🩺 Medical Instruments

Location

United States

Market Cap

USD 231.79 M

Share Price

USD 9.97

Avg Daily Volume

302,263

Change (1 day)

0.10%

Change (1 year)

-10.42%

Change (YTD)

-41.80%

Tactile Systems Technology, Inc. Share Price on June 20, 2025: USD 9.97

Tactile Systems Technology, Inc. Share Price is USD 9.97 on June 20, 2025, a -10.42% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Tactile Systems Technology, Inc. 52-week low Share Price is USD 19.54 on June 20, 2025, which is 95.99% above the current Share Price.
Tactile Systems Technology, Inc. 52-week low Share Price is USD 9.42 on June 20, 2025, which is -5.52% below the current Share Price.
Tactile Systems Technology, Inc. average Share Price for the last 52 weeks is USD 14.07.

Daily

From:

To:

Zoom:

Key data

Date	Share Price	Share Price	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)

NasdaqGM: TCMD

Tactile Systems Technology, Inc.

CEO	Ms. Sheri Louise Dodd
IPO Date	July 28, 2016
Location	United States
Headquarters	3701 Wayzata Boulevard
Employees	1,037
Sector	🏥 Health Care
Industries Telehealth 🧬 Biotechnology 🔬 Clinical Trials 🏥 Hospitals & Clinics 🩺 Medical Instruments

Description

Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.